Stephen A. Paget, MD, FACP, FACR
Dr. Stephen Paget is currently the Physician-in-Chief of the Department of Medicine, Division of Rheumatology of Hospital for Special Surgery and is also the Joseph P. Routh Professor of Medicine at the New York Hospital / Weill Cornell Medical College. He is also the Program Director of the Cornell Arthritis and Multipurpose Arthritis and Musculoskeletal Diseases Center (MAMDC) at Hospital for Special Surgery.
Appointments
Physician-in-Chief, Chairman of the Division of Rheumatology, Hospital for Special SurgeryJoseph P. Routh Professor of Medicine, Weill Cornell Medical College
Specialty
RheumatologySpecial Expertise
Polymyalgia rheumaticaVasculitis
Systemic lupus erythematosus
Wegener's granulomatosis
Awards
Arthritis Foundation Clinical Research Award, 1992J.J. Smith Memorial Award for Excellence in Teaching and Scholarship, New York Hospital, 1991
Arthritis Foundation Fellowship, 1975-78
Research Award presented at graduation, 1971
Rev. Mitchell General Excellence Award given to one student at graduation, 1971
Affiliations
American College of Rheumatology, FellowEducation
MD, Downstate Medical Center, Brooklyn, New YorkResidency
Johns Hopkins Hospital, Baltimore, MarylandFellowship
Hospital for Special Surgery, New York, New YorkCertification
Internal MedicineRheumatology
State Licensure
New YorkStephen A. Paget, MD, FACP, FACR is the author of the following articles on HSS.edu:
For Patients
- The Swine Flu: Information For Our Patients, Especially Those On Immunosuppressive Treatments
- The HSS Multidisciplinary Approach to Pain Control
- About the Surgical Arthritis Service at Hospital for Special Surgery
- The Modern Treatment of Chronic Pain
- Update on Osteoporosis
- Inflammatory Muscle Disorders: Their Diagnosis and Treatment
- Gout: An Interview with Dr. Paget and Dr. Simkin
- Detecting and Treating Pediatric Rheumatologic Problems - A Primer for Parents and Primary Care Pediatricians
- The Importance of Detecting Inflammatory Arthritis Early
- Modalities of Pain Management
- The Clinical and Immunological Personality of Rheumatoid Arthritis: An Interview with Experts
- "Early Diagnosis and Treatment of RA: A Therapeutic Window of Opportunity" FAQs
- Rheumatoid Arthritis: Myths and Realities
- Lupus Research, Medication, and Treatment: Past, Present, and Future
- Doctor-Patient Communication: An SLE Workshop Support Group summary
- What's New and Important in Lupus Research
- An In-Depth Overview of Rheumatoid Arthritis
- Rheumatoid Arthritis Treatments on the Horizon
- Uveitis and Other Eye Conditions in Rheumatology Patients
- The Age of Discovery: Rheumatology at Hospital for Special Surgery
- I am experiencing numbness at night in both arms and almost permanent numbness in my feet and ankles. Is this expected in RA? Is it treatable?
- Is Acupuncture an Effective Treatment for Rheumatoid Arthritis (RA)?
- FDA Alert Regarding Lupus Medication: an HSS Rheumatology Perspective
- Carpal Tunnel Syndrome: Electrodiagnostic Testing for a Proper Diagnosis
- A Brief Overview of Physiatry, Electrodiagnostics, and Injections
- Progressive Multifocal Leukoencephalopathy (PML) in Two Lupus Patients Treated with Rituximab (Rituxan): An HSS Rheumatology Perspective
- Special Report: Perspective on the recent data about celecoxib (Celebrex) and naproxen (Aleve)
- Special Report: Pfizer releases data raising question about cardiac safety of celecoxib (Celebrex)
- Bextra® Withdrawal from the Market - HSS Physicians Reflect on Options for Patients in Pain
- An HSS Response to “Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies: A systemic review and meta-analysis of rare harmful effects in randomized controlled trials”
- COX-2 Inhibitor Safety: HSS Physicians Reflect on the Recommendations of the FDA Advisory Panel
- How Medication Decisions are Made in RA Treatment
- Approach to the Child with Arthritis
- What is the prognosis if you have rheumatoid arthritis causing mild pulmonary hypertension and how common is it?
- Outcome Studies: The Way to Improved Care
- Is there something that can be done for frequent outbreaks of shingles (herpes Zoster)? I have severe RA and am taking Enbrel, methotrexate and folic acid.
- Is there anything that can be done for hair loss as a result of taking methotrexate or other medications for lupus?
- Is it worth trying Remicade even if Enbrel did not help me?
- Is it possible to combat RA with regular exercise and diet as opposed to taking steroids to decrease joint inflammation?
- Is gout related to rheumatoid arthritis?
- If the rheumatoid factor is very high in a person diagnosed with rheumatoid arthritis, does this determine the severity of the disease?
- I was diagnosed with RA three years ago. After being on a several different medications, I am only taking Celebrex and getting Enbrel injections. My doctor wants me to take Minocin, not specifically a drug for RA. Is this a common treatment?
- I have the symptoms of RA, but all of my lab work has been negative. How likely is it that I have RA?
- I have RA and I am on Warfarin for another problem. Is it true that if on Warfarin one cannot take any arthritis medications? If so, what should I do to deal with my RA?
- I have been on an antibiotic (augmentin) for the past 12 days due to an infection and noticed that my RA symptoms have lessened. Is there a connection between antibiotics and RA treatment?
- I find that rheumatologists never agree to surgical correction of the hands. Is there any special reason?
- I am doing well on Remicade and Celebrex. Do you have to take methotrexate if you are on Remicade?
- How long do you recommend to give a treatment before changing if remission has not occurred?
- Could Rheumatoid Arthritis cause my teeth to ache?
- Can Plaquenil cause ringing in the ears or hearing loss, and, if so, is the damage permanent?
- Are the nodules that grow on the muscle tendons of the legs common, and will they go away?
For Professionals
- Rheumatoid Arthritis - Board Review
- About the Surgical Arthritis Service at Hospital for Special Surgery
- Common Renal Problems in Rheumatology
- Uveitis and Other Eye Conditions in Rheumatology Patients
- Pregnancy in Autoimmune and Musculoskeletal Disease
- Mechanisms of Tissue Injury in Autoimmune Diseases such as Lupus; Autoimmune Disease and Atherosclerosis
- Immunology of Inflammatory Bowel Disease and Treatment with TNF-inhibitor
- Clinical Outcomes Research: Methods, Ethical Issues, and Benefits
- Approach to the Child/Adolescent with Arthritis
- Outcome Studies: The Way to Improved Care
- Cytokines in Inflammatory Disease
- Positron Emission Tomography (PET Scan) in the Diagnosis and Assessment of Connective Tissue Disorders
- High-Risk Pregnancy in Lupus Patients
- New Developments in Fibromyalgia
- Rheumatoid Arthritis: Systemic Disorder with Major Collateral Damage - Board Review
- Gout: An Interview with Dr. Paget and Dr. Simkin
- Detecting and Treating Pediatric Rheumatologic Problems - A Primer for Parents and Primary Care Pediatricians
- The Role of Infections in Arthritis and Spondyloarthropathies
- The Clinical and Immunological Personality of Rheumatoid Arthritis: An Interview with Experts
- Early Inflammatory Arthritis Group Workshops
- Modalities of Pain Management
- Inflammatory Muscle Disorders: Diagnosis and Treatment
- Five-Year Survival in a Cohort of Hip Fracture Patients: The Predictive Role of Pre-fracture Health Status
- The Age of Discovery: Rheumatology at Hospital for Special Surgery
- FDA Alert Regarding Lupus Medication: an HSS Rheumatology Perspective
- Progressive Multifocal Leukoencephalopathy (PML) in Two Lupus Patients Treated with Rituximab (Rituxan): An HSS Rheumatology Perspective
- Special Report: Perspective on the recent data about celecoxib (Celebrex) and naproxen (Aleve)
- Special Report: Pfizer releases data raising question about cardiac safety of celecoxib (Celebrex)
- Bextra® Withdrawal from the Market - HSS Physicians Reflect on Options for Patients in Pain
- An HSS Response to “Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies: A systemic review and meta-analysis of rare harmful effects in randomized controlled trials”
- COX-2 Inhibitor Safety: HSS Physicians Reflect on the Recommendations of the FDA Advisory Panel
Selected Publications
For more publications, please see the PubMed listing.
Research Description
Clinical investigation into the pathogenesis and optimal treatment of rheumatoid arthritis, systemic lupus erythematosus, the systemic vasculitides, premature atherosclerosis associated with autoimmune disorders and steroid-induced osteoporosis.
Clinical Trials
Office Locations
Hospital for Special Surgery
7th Floor
535 East 70th Street
New York, NY 10021
Tel: 212.606.1845
Fax: 212.606.1170
7th Floor
535 East 70th Street
New York, NY 10021
Tel: 212.606.1845
Fax: 212.606.1170
Mailing Address
Hospital for Special Surgery535 East 70th Street
New York, New York 10021
Patient Stories:
Dr. Paget In the News:
- Contact HSS
- Give to HSS
- Maps and Directions
- Notice of Privacy Practices
- Terms of Use
- Joint Commission Notice
- HSS Staff Login
©2008 Hospital for Special Surgery. 535 East 70th Street, New York, NY 10021